Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carcinoembryonic antigen-related cell adhesion molecule 8 (CEACAM8/CD66b) is an immunoglobulin superfamily glycoprotein expressed mainly on human granulocytes where it regulates cellular adhesion, migration, pathogen binding, inflammation modulation, immune response regulation—and acts as an important biomarker for granulocyte activity under physiological or pathological conditions including infection and cancer progression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carcinoembryonic antigen-related cell adhesion molecule 8 (CEACAM8).